Corbus Pharmaceuticals appoints director
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Essential IR Insights Newsletter - Summer July-August 2023
Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits
Corbus Pharmaceuticals Holdings Inc. added Paris Panayiotopoulos to its board.
Panayiotopoulos was the president and CEO of ARIAD Pharmaceuticals Inc. prior to its acquisition by Takeda Pharmaceutical Co. Ltd.
